Roy A. Whitfield

Director, Incyte.

Companies

Nektar TherapeuticsBoard member Sep 22, 2006 to now¹
IlluminaBoard member Feb 1, 2007 to Aug 15, 2016²
IncyteBoard member Jan 4, 2006 to Jan 17, 2014³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Nektar Therapeutics NKTR17,751 shares⁴$669.6K at $37.72Sep 25, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 23, 2026Granted 2,000 shares of Nektar Therapeutics⁴
Jun 14, 2023Sold 30,000 shares at $0.57 of Nektar Therapeutics⁵
Sep 16, 2022Granted 10,200 shares of Nektar Therapeutics⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNektar Therapeutics, Board member
2
SEC EDGARIllumina, Board member
3
SEC EDGARIncyte, Board member
4
SEC EDGARNektar Therapeutics shares after the filing of Sep 25, 2026
5
SEC EDGARForm 4 filed Jun 15, 2023
6
SEC EDGARForm 4 filed Sep 20, 2022